United Services Automobile Association Crispr Therapeutics Ag Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $287,989 - $536,447	-12,670 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$44.35 - $65.71 $641,434 - $950,363	-14,463 Reduced 53.3%	12,670 $562,000
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $31,240 - $53,941	733 Added 2.78%	27,133 $1.59 Million
Q1 2018 May 14, 2018	SELL	$23.52 - $58.17 $406,896 - $1.01 Million	-17,300 Reduced 39.59%	26,400 $1.21 Million
Q4 2017 Feb 14, 2018	SELL	$16.95 - $23.48 $708,510 - $981,464	-41,800 Reduced 48.89%	43,700 $1.03 Million
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $1.43 Million - $1.77 Million	85,500	85,500 $1.53 Million

493

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.85B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.